CTNNB1 and malignant colon neoplasm: Among the newly identified immunopeptidome-evidenced neoantigens, we highlight shared neoantigens in colon cancer derived from frameshift mutations in LARP4B, as well as a missense mutation, CTNNB1 T41A, a driver gene in liver cancer.